Citation Impact
Citing Papers
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers
2018 StandoutNobel
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
2010 StandoutScience
Inducible Foxp3 + regulatory T-cell development by a commensal bacterium of the intestinal microbiota
2010 Standout
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
Trained immunity: A program of innate immune memory in health and disease
2016 StandoutScience
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
2013 StandoutScienceNobel
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
2011
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells
2009
CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes
2016
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Regulatory T-cell directed therapies in liver diseases
2013 StandoutNobel
Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
2019
FOXP3 Expression in Hepatitis C Virus–Specific CD4+ T Cells During Acute Hepatitis C
2009
Turning Tumors into Vaccines: Co-opting the Innate Immune System
2013
Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice
2012
Increased Regulatory T Cells Correlate With CD8 T-Cell Impairment and Poor Survival in Hepatocellular Carcinoma Patients
2007
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
Regulatory T cells in virus infections
2006
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures
2010 StandoutNobel
New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus
2016
Liver-test abnormalities in sarcoidosis
2011
New insight in the pathobiology of hepatitis B virus infection
2012
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
2007 StandoutNature
Lung Transplantation in Sarcoidosis
2007
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Keeping NK cells in highly regulated antiviral warfare
2007
Hepatitis B cure: From discovery to regulatory approval
2017
Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa–Dependent Manner
2009
PD-1/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection
2010
Natural regulatory T cells and parasites: a common quest for host homeostasis
2006
Expression of inhibitory markers is increased on effector memory T cells during hepatitis C virus/HIV coinfection as compared to hepatitis C virus or HIV monoinfection
2013
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
Sarcoidosis
2013 Standout
Functions of natural killer cells
2008 Standout
Molecular biology of hepatitis B virus infection
2015
A Jekyll and Hyde Profile: Type 1 Interferon Signaling Plays a Prominent Role in the Initiation and Maintenance of a Persistent Virus Infection
2015
Redefining Chronic Viral Infection
2009
Cell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells
2008 StandoutNobel
Living in the liver: hepatic infections
2012
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
2013
Optimal management of hepatitis B virus infection – EASL Special Conference
2015
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Immunopathogenesis of Hepatic Flare in HIV/Hepatitis B Virus (HBV)–Coinfected Individuals after the Initiation of HBV‐Active Antiretroviral Therapy
2009
Hepatitis B virus infection
2018
Microenvironmental regulation of metastasis
2008 Standout
Cellular and Molecular Mechanisms of Liver Injury
2008
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
The role of innate immunity in the immunopathology and treatment of HBV infection
2016
Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B
2012
Trained immunity in newborn infants of HBV-infected mothers
2015
Adaptive immunity in HBV infection
2016
Inhibitory Phenotype of HBV-Specific CD4+ T-Cells Is Characterized by High PD-1 Expression but Absent Coregulation of Multiple Inhibitory Molecules
2014
Antigen-presenting cell function in the tolerogenic liver environment
2010
Sarcoidosis
2007 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Defining and using immune archetypes to classify and treat cancer
2023
Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B
2009
Hepatocellular Carcinoma
2019 Standout
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
2009 Standout
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
2014
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
Regulatory T Cells in the Control of Host-Microorganism Interactions
2009
New Insights into how HBV Manipulates the Innate Immune Response to Establish Acute and Persistent Infection
2013
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Impact of β2 integrin deficiency on mouse natural killer cell development and function
2011 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Ipilimumab Administration in Patients With Advanced Melanoma and Hepatitis B and C
2013
Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection
2016
Cutting Edge: Priming of NK Cells by IL-18
2008 StandoutNobel
High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein
2007 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
TLRs and innate immunity
2008 StandoutNobel
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
2020
Genetic and Epigenetic Regulation of PD-1 Expression
2016
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Induced CD4+Foxp3+Regulatory T Cells in Immune Tolerance
2012
Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease
2019
Review article: long‐term safety of nucleoside and nucleotide analogues in HBV ‐monoinfected patients
2016
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
The Liver as a Lymphoid Organ
2009
Expansion of Dysfunctional Tim-3–Expressing Effector Memory CD8+ T Cells during Simian Immunodeficiency Virus Infection in Rhesus Macaques
2014
Characterization of Human Antiviral Adaptive Immune Responses during Hepatotropic Virus Infection in HLA-Transgenic Human Immune System Mice
2013 StandoutNobel
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Interleukin-2 Functionalized Nanocapsules for T Cell-Based Immunotherapy
2016
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Extrapulmonary sarcoidosis of liver and pancreas: A case report and review of literature
2007
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Works of Patrick Kennedy being referenced
Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection
2008
Modulation of the CD8 + -T-Cell Response by CD4 + CD25 + Regulatory T Cells in Patients with Hepatitis B Virus Infection
2005
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis
2017
Toll-Like Receptor 8 Agonist and Bacteria Trigger Potent Activation of Innate Immune Cells in Human Liver
2014
Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection
2011
The immune tolerant phase of chronic HBV infection: new perspectives on an old concept
2014
Preserved T-Cell Function in Children and Young Adults With Immune-Tolerant Chronic Hepatitis B
2012
The influence of T cell cross-reactivity on HCV-peptide specific human T cell response
2006
Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells
2015
Natural history of hepatic sarcoidosis and its response to treatment
2006
Targeted delivery of interferon-α to hepatitis B virus-infected cells using T-cell receptor-like antibodies
2012
Upregulation of the Tim-3/Galectin-9 Pathway of T Cell Exhaustion in Chronic Hepatitis B Virus Infection
2012
Mobilizing monocytes to cross-present circulating viral antigen in chronic infection
2013
The Third Signal Cytokine IL-12 Rescues the Anti-Viral Function of Exhausted HBV-Specific CD8 T Cells
2013
Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus Infection
2010
Assessment of Bone Mineral Density in Tenofovir-Treated Patients With Chronic Hepatitis B: Can the Fracture Risk Assessment Tool Identify Those at Greatest Risk?
2014
HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant
2016
The Level of Viral Antigen Presented by Hepatocytes Influences CD8 T-Cell Function
2007
713 FACTORS DETERMINING BONE MINERAL DENSITY LOSS IN CHRONIC HEPATITIS B PATIENTS: IS TENOFOVIR DISOPROXIL FUMARATE THE MAIN CULPRIT?
2011
Targeting Hepatitis B Virus-Infected Cells with a T-Cell Receptor-Like Antibody
2010
A Genotype-Specific Baseline Score to Predict Response at 48 Weeks Post-Treatment to Peginterferon Alfa-2a in Patients with HBeAg-Negative Chronic Hepatitis B
2016
IL-10–Producing Regulatory B Cells in the Pathogenesis of Chronic Hepatitis B Virus Infection
2012
Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage
2007
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion
2012
IL-2–Engineered nano-APC Effectively Activates Viral Antigen-Mediated T Cell Responses from Chronic Hepatitis B Virus-Infected Patients
2011